Clinical Trials
2 trialsNCT01613261 2013-11-01
Study of TAK-733 in Combination With Alisertib in Adult Patients With Advanced Nonhematologic Malignancies
Millennium Pharmaceuticals, Inc.
Phase 1 Withdrawn
NCT00948467 2013-07-02
Study of TAK-733 in Adult Patients With Advanced Nonhematologic Malignancies
Millennium Pharmaceuticals, Inc.
Phase 1 Completed